Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial by Tito R. Mendoza, David S. Hong, Christine B. Peterson, Bettzy Stephen, Ecaterina Dumbrava, Shubbam Pant, Apostolia Maria Tsimberidou, Timothy Anthony Yap, Ajay Sheshadri, Mehmet Altan, Goldy George, Lilibeth Castillo, Enedelia Rodriguez, Jing Gong, Vivek Subbiah, Filip Janku, Siqing Fu, Sarina A. Piha-Paul, Jordi Rodon Ahnert, Daniel D. Karp, Charles Cleeland, Funda Meric-Bernstam, Aung Naing

Get full text